Advertisement
UK markets close in 2 hours 39 minutes
  • FTSE 100

    8,385.58
    -38.62 (-0.46%)
     
  • FTSE 250

    20,798.14
    -75.19 (-0.36%)
     
  • AIM

    807.94
    -2.00 (-0.25%)
     
  • GBP/EUR

    1.1703
    +0.0005 (+0.05%)
     
  • GBP/USD

    1.2707
    +0.0000 (+0.00%)
     
  • Bitcoin GBP

    56,117.81
    +3,498.43 (+6.65%)
     
  • CMC Crypto 200

    1,541.24
    +52.69 (+3.54%)
     
  • S&P 500

    5,308.13
    +4.86 (+0.09%)
     
  • DOW

    39,806.77
    -196.82 (-0.49%)
     
  • CRUDE OIL

    78.45
    -1.35 (-1.69%)
     
  • GOLD FUTURES

    2,432.60
    -5.90 (-0.24%)
     
  • NIKKEI 225

    38,946.93
    -122.75 (-0.31%)
     
  • HANG SENG

    19,220.62
    -415.60 (-2.12%)
     
  • DAX

    18,659.89
    -109.07 (-0.58%)
     
  • CAC 40

    8,107.87
    -88.09 (-1.07%)
     

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024

Vistin Pharma ASA
Vistin Pharma ASA

Oslo, Norway, 30 April 2024

Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 23 May 2024 at 13:00 CEST.

A physical Annual General Meeting will not be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of proxy, see general information at the bottom of the notice and enclosed proxy forms.

ADVERTISEMENT

The recommendation from the Election Committee is available on the Company's website. The formal call will be sent to all shareholders registered in the Norwegian Central Security Depository (VPS) and are also attached to this announcement.

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

 

 

Attachments